Events Partner Content 3rd Microbiome Movement - Drug Development Europe Recent breakthroughs in DNA sequencing, metagenomic analysis and computational techniques have given scientists new insight into the structure and function of the human microbiota, an interconnecte
News Secretive Moderna could finally go public with $500m IPO RNA medicine specialist Moderna is attempting the biggest IPO in biotech history, after applying to raise $500 million from investors.
Partner Content Partner Content New collaboration will advance human-based drug evaluation Medicines Discovery Catapult and the Medical Research Council (MRC) Centre for Drug Safety
Partner Content Partner Content Overcoming bottlenecks in early drug discovery with the powe... Medicines Discovery Catapult and AstraZeneca collaborate to unlock the potential of Acoustic Mist Ionisation Mass Spectrometry
News Amgen invests £50m in UK genetics firm Oxford Nanopore Biotech giant Amgen has ploughed £50 million into a genetic sequencing company to support the development of its cutting-edge technology.
News Crescendo hires ex-Roche R&D guru to develop T-cell technolo... Biotech has already raised $70m this year in second funding round
News Neuralink unveils trial linking brain implant to robotic arm Neuralink has been given regulatory approval to start a new trial of its brain implant to see if it can be used to control a robotic arm
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.